KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response https://www.biorxiv.org/content/10.1101/2023.01.01.522340v1?med=mas
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.